Andrea Wang-Gillam, MD, PhD, discusses a trial looking at PF-04136309, an investigational chemokine receptor antagonist, in combination with FOLFIRINOX for the treatment of locally advanced pancreatic cancer.
Andrea Wang-Gillam, MD, PhD
Articles by Andrea Wang-Gillam, MD, PhD
Latest Updated Articles
Treatment With a Monocyte-Targeting Agent for Pancreatic CancerPublished: January 19th 2015 | Updated: